Scripps Research Institute is ranked among medical research organizations in La Jolla, CA, with an America's Best Score of 71 out of 100, based on its 2025 Form 990.
Scripps Research Institute is a 501(c)(3) organization, classified under Medical Research (NTEE H92). Contributions are tax-deductible.
10550 N Torrey Pines Rd, La Jolla, CA 92037-1000
Among the 4 scored medical research organizations in La Jolla, Scripps Research Institute holds 25.8 months of operating reserves (peer median 27.4 months), runs a typical yearly surplus of 25.7% (peers: surplus of 5.7%), and has cut spending 15.3% a year (peers: grown spending 2.7% a year).
In fiscal year 2025 it reported $698,624,318 in revenue and $537,453,981 in expenses, with contributions making up 45.5% of revenue.
The Scripps Research Institute ("tsri") performs high impact basic biomedical research, improves the human condition by fostering translation of its discoveries into useful products and engages in the highest quality graduate scientific education and post graduate scientific training. Tsri is known for its entrepreneurial environment and its emphasis in research relating to synthetic chemistry, the relationship between molecular structure and activity and chemical biology.
Largest programs · fiscal year 2025
Groundbreaking scientific research is conducted at tsri campuses in La Jolla, California, supported by grants, contracts and fellowships from public and private institutes and individuals. Tsri's unique structure merges basic scientific studies in biology, chemistry and bioinformatics with translational science to produce the next generation of drugs and advances in digital and precision medicine.… Read more
Groundbreaking scientific research is conducted at tsri campuses in La Jolla, California, supported by grants, contracts and fellowships from public and private institutes and individuals. Tsri's unique structure merges basic scientific studies in biology, chemistry and bioinformatics with translational science to produce the next generation of drugs and advances in digital and precision medicine. Scientific discoveries at tsri seed joint drug discovery projects at calibr-skaggs, a division of tsri, creating a pipeline of drug candidates that will impact patients for years to come. The scripps research translational institute, another division of tsri, aims to individualize healthcare by leveraging the progress being made in human genomics and combining it with the power of wireless digital technologies and artificial intelligence.
$473,621,099 spent · 95.8% of program spending
Tsri is committed to educating, training and inspiring the scientists of tomorrow. The institute's skaggs graduate school of chemical and biological sciences, ranked one of the ten best graduate programs in the country, empowers students to make high-impact discoveries at the interface of chemistry and biology. Students in the skaggs graduate school are immersed in intensive laboratory research fr… Read more
Tsri is committed to educating, training and inspiring the scientists of tomorrow. The institute's skaggs graduate school of chemical and biological sciences, ranked one of the ten best graduate programs in the country, empowers students to make high-impact discoveries at the interface of chemistry and biology. Students in the skaggs graduate school are immersed in intensive laboratory research from day one and pursue ambitious investigations across scientific disciplines. Graduates of the school become educators at top universities and research institutes, thought leaders within government departments and innovators at pharmaceutical and biotechnology companies. Postdoctoral associates arrive at tsri from all over the globe, seeking to expand their knowledge and training by working alongside our world-renowned scientists. The scripps fellows program identifies individuals with an outstanding record of graduate research and moves them into their own laboratories, allowing them to leapfrog their postdoctoral years of study and begin pushing the frontiers of scientific discovery.
$20,835,219 spent · 4.2% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 92¢ went to programs, 7¢ to management and 1¢ to fundraising.
Programs $494,456,318
Management $35,456,668
Fundraising $7,540,995
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
92%
Meets
Compared with La Jolla peers
Measure
This organization
Peer median
Operating reserves
25.8 mo
27.4 mo
Typical margin
+25.7%
+5.7%
Spending growth
−15.3% / yr
+2.7% / yr
Debt load
21.0%
37.5%
Peers: the 4 La Jolla medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$698,624,318Fiscal year 2025
Expenses$537,453,981Fiscal year 2025
Total assets$1,460,616,898Fiscal year 2025
Total liabilities$306,765,344Fiscal year 2025
Fiscal year ending September2025
Revenue$698,624,318
Expenses$537,453,981
Net income$161,170,337
Net assets$1,153,851,554
Notable sources of revenue
Percent of total revenue
Contributions
$317,961,835
45.5%
Program services
$1,811,390
0.3%
Investment income
$36,569,701
5.2%
Other (net)
$342,281,392
49.0%
Assets / debt
Total assets
$1,460,616,898
Total liabilities
$306,765,344
Net assets
$1,153,851,554
Compensation
Not in our extract for this year.
Fiscal year ending September2024
Revenue$641,106,163
Expenses$528,437,793
Net income$112,668,370
Net assets$931,789,215
Notable sources of revenue
Percent of total revenue
Contributions
$370,268,955
57.8%
Program services
$2,212,057
0.3%
Investment income
$30,267,045
4.7%
Other (net)
$238,358,106
37.2%
Assets / debt
Total assets
$1,299,917,796
Total liabilities
$368,128,581
Net assets
$931,789,215
Compensation
Not in our extract for this year.
Fiscal year ending September2023
Revenue$815,837,195
Expenses$532,639,503
Net income$283,197,692
Net assets$758,238,281
Notable sources of revenue
Percent of total revenue
Contributions
$395,238,681
48.4%
Program services
$6,286,258
0.8%
Investment income
$19,199,399
2.4%
Other (net)
$395,112,857
48.4%
Assets / debt
Total assets
$1,088,712,998
Total liabilities
$330,474,717
Net assets
$758,238,281
Compensation
Not in our extract for this year.
Fiscal year ending September2022
Revenue$634,980,417
Expenses$884,961,642
Net income−$249,981,225
Net assets$448,836,848
Notable sources of revenue
Percent of total revenue
Contributions
$385,396,446
60.7%
Program services
$1,280,071
0.2%
Investment income
$3,644,864
0.6%
Other (net)
$244,659,036
38.5%
Assets / debt
Total assets
$828,320,768
Total liabilities
$379,483,920
Net assets
$448,836,848
Compensation
Officers and key employees
$4,466,925
Share of expenses
0.5%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?